Search Results

Multiple Myeloma : Risk Factors, Diagnosis, and Treatments

• Authors : Holt, Steve

Subjects: Multiple myelomaMEDICAL / Evidence-Based Medicine; HEALTH & FITNESS / Diseases & Conditions / General; MEDICAL / Clinical Medicine

Record details

Multiple Myeloma

• Authors : Kumar, Shaji

Subjects: Multiple myelomaMEDICAL / Oncology / General

Record details

BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma.

• Authors : Lu, Qizhong¹ (AUTHOR); Li, Hexian¹ (AUTHOR); Wu, Zhiguo¹ (AUTHOR)

• Source: Journal of Nanobiotechnology. 5/23/2024, Vol. 22 Issue 1, p1-19. 19p.

Record details

G-Quadruplex Forming DNA Sequence Context Is Enriched around Points of Somatic Mutations in a Subset of Multiple Myeloma Patients.

• Authors : Zhuk, Anna S.^1,2 (AUTHOR) ; Stepchenkova, Elena I.^3,4 (AUTHOR) ; Zotova, Irina V.^1,3 (AUTHOR)

Subjects: *SOMATIC mutation; *MULTIPLE myeloma; *NUCLEOTIDE sequence

• Source: International Journal of Molecular Sciences. May2024, Vol. 25 Issue 10, p5269. 18p.

Record details

An Assessment of the Effectiveness and Safety of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma Patients with Relapsed or Refractory Disease: A Systematic Review and Meta-Analysis.

• Authors : Pereira, Rita¹ (AUTHOR) ; Bergantim, Rui^2,3,4,5 (AUTHOR)

Subjects: *CHIMERIC antigen receptors; *MULTIPLE myeloma; *CYTOKINE release syndrome

• Source: International Journal of Molecular Sciences. May2024, Vol. 25 Issue 9, p4996. 25p.

Record details

Effects on the Physical Functioning of Two Exercise Interventions in Patients with Multiple Myeloma: A Pilot Feasibility Study.

• Authors : Hillengass, Jens¹ (AUTHOR) ; Hillengass, Michaela² (AUTHOR); Joseph, Janine M.² (AUTHOR)

• Source: Cancers. May2024, Vol. 16 Issue 9, p1774. 13p.

Record details

Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy.

• Authors : Wang, Yanmeng¹ (AUTHOR); Vandewalle, Niels¹ (AUTHOR); De Veirman, Kim^1,2 (AUTHOR)

• Source: Cell Communication & Signaling. 6/11/2024, Vol. 22 Issue 1, p1-17. 17p.

Record details

Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities.

• Authors : Heestermans, Robbe^1,2,3 (AUTHOR); Schots, Rik^2,3 (AUTHOR); De Becker, Ann^2,3 (AUTHOR)

Subjects: *MULTIPLE myeloma; *CELL-free DNA; *DISEASE relapse

• Source: International Journal of Molecular Sciences. May2024, Vol. 25 Issue 10, p5208. 15p.

Record details

Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands.

• Authors : Díaz-Tejedor, Andrea^1,2 (AUTHOR) ; Rodríguez-Ubreva, Javier³ (AUTHOR) ; Ciudad, Laura³ (AUTHOR)

Subjects: *DARATUMUMAB; *MULTIPLE myeloma; *CD38 antigen

• Source: International Journal of Molecular Sciences. May2024, Vol. 25 Issue 9, p4718. 15p.

Record details

Clinical outcomes of pomalidomide‐based and daratumumab‐based therapies in patients with relapsed/refractory multiple myeloma: A real‐world cohort study in China.

• Authors : Han, Xiaoyan¹ (AUTHOR); Jiang, Xincheng¹ (AUTHOR); He, Jingsong¹ (AUTHOR)

• Source: Cancer Medicine. May2024, Vol. 13 Issue 9, p1-15. 15p.

Record details